Dear Joe Biden…

Published January 22, 2021

APC led the effort to gather partners across the compounding pharmacy spectrum to sign a joint letter to the incoming Biden administration on compounding priorities.

It covers shortage compounding, reimbursement challenges, the FDA’s MOU on interstate shipments, threats to cBHT, and more — the critical issues facing compounders and their patients.

During the current public health emergency (PHE), compounded medications have served as a
vital resource for patients to address regional and national shortages of critical medical resources
— from medications to assist with ventilated COVID patients to ensuring an adequate supply of
hand sanitizer. Given the critical value of these guidance documents, we urge the agency to
extend them beyond the PHE.

A big thanks to the organizations that joined us in the letter: the Alliance for Natural Health, American Academy of Ophthalmology, American Association of Naturopathic Physicians, American Pharmacists Association, American Society of Cataract and Refractive Surgery, American Society of Consultant Pharmacists, Empower Pharmacy, Letco Medical, Medisca, National Alliance of State Pharmacy Associations, National Community Pharmacists Association, OSRX, and PCCA.

Read the entire letter here (PDF).